Drug profile · INN
tolcapone
TASMAR
tolcapone (TASMAR) is a catechol o-methyltransferase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — tolcapone
- US status
- approved
- Class
- Nervous system (N04)
- Route
- ORAL
- Patents
- 0
- Programs
- 3
- Data quality
- 0.84
Quick answer
tolcapone (TASMAR) is a catechol o-methyltransferase inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Catechol O-methyltransferase inhibitor
Primary target: Catechol O-methyltransferase
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is tolcapone?
tolcapone (TASMAR) is a catechol o-methyltransferase inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tolcapone?
TASMAR is a marketed brand name for tolcapone. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tolcapone?
tolcapone has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.